Literature DB >> 25236481

The psychological impact of predictive genetic testing for Huntington's disease: a systematic review of the literature.

S Crozier1, N Robertson, M Dale.   

Abstract

Huntington's disease (HD) is a neurodegenerative genetic condition for which a predictive genetic test by mutation analysis has been available since 1993. However, whilst revealing the future presence of the disease, testing may have an adverse psychological impact given that the disease is progressive, incurable and ultimately fatal. This review seeks to systematically explore the psychological impact of genetic testing for individuals undergoing pre-symptomatic mutation analysis. Three databases (Medline, PsycInfo and Scopus) were interrogated for studies utilising standardised measures to assess psychological impact following predictive genetic testing for HD. From 100 papers initially identified, eight articles were eligible for inclusion. Psychological impact of predictive genetic testing was not found to be associated with test result. No detrimental effect of predictive genetic testing on non-carriers was found, although the process was not found to be psychologically neutral. Fluctuation in levels of distress was found over time for carriers and non-carriers alike. Methodological weaknesses of published literature were identified, notably the needs of individuals not requesting genetic testing, as well as inadequate support for individuals registering elevated distress and declining post-test follow-up. Further assessment of these vulnerable individuals is warranted to establish the extent and type of future psychological support.

Entities:  

Mesh:

Year:  2014        PMID: 25236481     DOI: 10.1007/s10897-014-9755-y

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  62 in total

1.  Randomised controlled trial of psychological debriefing for victims of acute burn trauma.

Authors:  J I Bisson; P L Jenkins; J Alexander; C Bannister
Journal:  Br J Psychiatry       Date:  1997-07       Impact factor: 9.319

Review 2.  Huntington's disease genetics.

Authors:  Richard H Myers
Journal:  NeuroRx       Date:  2004-04

Review 3.  Psychosocial effects of predictive testing for Huntington's disease.

Authors:  Michael R Hayden; Yvonne Bombard
Journal:  Adv Neurol       Date:  2005

4.  Does Early Psychological Intervention Promote Recovery From Posttraumatic Stress?

Authors:  Richard J McNally; Richard A Bryant; Anke Ehlers
Journal:  Psychol Sci Public Interest       Date:  2003-11-01

Review 5.  Predictive genetic testing: psychological factors.

Authors:  P M Salkovskis; K A Rimes
Journal:  J Psychosom Res       Date:  1997-11       Impact factor: 3.006

6.  Predictive genetic testing and the making of the pre-symptomatic person: Prognostic moralities amongst Huntington's-affected families.

Authors:  Monica Konrad
Journal:  Anthropol Med       Date:  2003

Review 7.  The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.

Authors:  Tamara Pringsheim; Katie Wiltshire; Lundy Day; Jonathan Dykeman; Thomas Steeves; Nathalie Jette
Journal:  Mov Disord       Date:  2012-06-12       Impact factor: 10.338

8.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

Authors:  M Huggins; M Bloch; S Wiggins; S Adam; O Suchowersky; M Trew; M Klimek; C R Greenberg; M Eleff; L P Thompson
Journal:  Am J Med Genet       Date:  1992-02-15

9.  Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea.

Authors:  A Tyler; P S Harper
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

10.  Psychiatric implications of presymptomatic testing for Huntington's disease.

Authors:  Seymour Kessler
Journal:  Am J Orthopsychiatry       Date:  1987-04
View more
  20 in total

1.  Qualitative Research on Expanded Prenatal and Newborn Screening: Robust but Marginalized.

Authors:  Rachel Grob
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

2.  What to Do with a Second Chance in Life? Long-Term Experiences of Non-carriers of Huntington's Disease.

Authors:  Elisabeth Winnberg; Ulrika Winnberg; Lilian Pohlkamp; Anette Hagberg
Journal:  J Genet Couns       Date:  2018-04-07       Impact factor: 2.537

3.  Reconceptualizing harms and benefits in the genomic age.

Authors:  Anya E R Prince; Benjamin E Berkman
Journal:  Per Med       Date:  2018-09-27       Impact factor: 2.512

4.  Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).

Authors:  K A Quaid; S W Eberly; E Kayson-Rubin; D Oakes; I Shoulson
Journal:  Clin Genet       Date:  2016-11-24       Impact factor: 4.438

Review 5.  Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.

Authors:  J Scott Roberts; Anne K Patterson; Wendy R Uhlmann
Journal:  Neurobiol Dis       Date:  2020-04-14       Impact factor: 5.996

6.  Assessing the Psychological Impact of Genetic Susceptibility Testing.

Authors:  J Scott Roberts
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

Review 7.  Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.

Authors:  Scott Y H Kim; Jason Karlawish; Benjamin E Berkman
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

8.  Psychiatric genetics researchers' views on offering return of results to individual participants.

Authors:  Kristin M Kostick; Cody Brannan; Stacey Pereira; Gabriel Lázaro-Muñoz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-10-25       Impact factor: 3.568

9.  Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.

Authors:  Jill O Robinson; Julia Wynn; Barbara Biesecker; Leslie G Biesecker; Barbara Bernhardt; Kyle B Brothers; Wendy K Chung; Kurt D Christensen; Robert C Green; Amy L McGuire; M Ragan Hart; Ida Griesemer; Donald L Patrick; Christine Rini; David Veenstra; Angel M Cronin; Stacy W Gray
Journal:  Genet Med       Date:  2019-06-13       Impact factor: 8.822

10.  Avoiding "toxic knowledge": the importance of framing personalized risk information in clinical decision-making.

Authors:  Kristin M Kostick; J S Blumenthal-Barby
Journal:  Per Med       Date:  2021-02-22       Impact factor: 2.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.